Subtype Transdifferentiation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression
The classification of tumors into subtypes, characterized by phenotypes determined by specific differentiation pathways, aids diagnosis and directs therapy towards targeted approaches. However, with the advent and explosion of next-generation sequencing, cancer phenotypes are turning out to be far m...
Main Authors: | Monica Fedele, Laura Cerchia, Sabrina Battista |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/13/4/350 |
Similar Items
-
Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer
by: Zoe R. Maylin, et al.
Published: (2024-12-01) -
Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
by: Lina Merkens, et al.
Published: (2022-02-01) -
Neuroendocrine transdifferentiation in human cancer: molecular mechanisms and therapeutic targets
by: Jun Jiang, et al.
Published: (2024-10-01) -
Chemical Transdifferentiation of Somatic Cells: Unleashing the Power of Small Molecules
by: Yu Zhang, et al.
Published: (2023-10-01) -
Mesenchymal and stemness transdifferentiation via in-vitro infection of T24 cell line with Klebsiella pneumoniae
by: Romaila Abd-El-Raouf, et al.
Published: (2023-06-01)